Skip to main navigation Skip to search Skip to main content

Oral Anticoagulation and antithrombotic Therapy in Patients with Atrial Fibrillation after percutaneous Coronary Intervention - with special Reference to Dabigatran

  • K Huber
  • , G Delle Karth
  • , H Frank
  • , T Gremmel
  • , C Madl
  • , A Niessner
  • , T Neunteufl
  • , W Pirker
  • , B Watschinger
  • , F Weidinger
  • , T Weiss
  • , Uta Hoppe (Co-author)
  • , J Auer
  • , RK Binder
  • , P Siostrzonek
  • , C Steinwender
  • , T Sturmberger
  • , M Vosko
  • , H Wallner
  • , R Zweiker
  • H Alber, K Dritan, A Kirsch, M Kneihsl, R Raggam, D Scherr, V Stadlbauer-Kollner, A Zirlik

Research output: Contribution to journalReview articlepeer-review

Original languageGerman
Pages (from-to)3-12
JournalJournal für Kardiologie
Volume27
Publication statusPublished - 2020

Keywords

  • RIVAROXABAN
  • METAANALYSIS
  • PREVENTION
  • APIXABAN
  • EFFICACY
  • WARFARIN
  • STROKE
  • SAFETY

Cite this